Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALF

Recent news which mentions ESALF

< Previous 1 2 Next >
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
Tickers BIIB ESAIY ESALF NEWS
Tags BIIB ESAIY Market News
From Benzinga
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Tickers BIIB ESALF ESALY LLY
Tags Top Stories Health Care LLY
From Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Tickers BIIB BMY ESALF JNJ
Tags medicare Shivdeep Dhaliwal Bernie Sanders
From Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
Tickers BIIB ESAIY ESALF LLY
Tags Market News Analyst Color ESAIY
From Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
Tickers BIIB ESALF LLY NEWS
Tags Equities News AI Generated
From Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
Tickers BIIB ESALF ESALY NEWS
Tags General Biotech Movers
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags Market News MRK General
From Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
Tickers BIIB ESALF SPX
Tags BIIB ESALF SPX
From MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
Tickers BIIB ESALF JNJ LLY
Tags BIIB MRK PFE
From MarketWatch
Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge
Tickers BIIB ESALF LLY SPX
Tags LLY SPX ESALF
From MarketWatch
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
Tickers BIIB ESALF LLY
Tags BIIB LLY ESALF
From MarketWatch
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
Tickers BIIB ESALF ESALY LLY
Tags General ESALY Benzinga
From Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
Tickers BIIB ESALF ESALY LLY
Tags ESALF Health Care LLY
From Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Tickers AA AAPL AMZN BIIB
Tags F Benzinga PFE
From Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
Tickers BIIB ESALF ESALY
Tags Briefs News Biotech
From Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
Tickers ESALF ESALY MRK
Tags Benzinga ESALF ESALY
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
Tickers ESALF ESALY MRK
Tags Market News MRK General
From Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Tickers BIIB DGX ESALF LLY
Tags LLY SPX ESALF
From MarketWatch
Biogen to slash 1,000 jobs as it looks to save $700 million
Tickers BIIB ESALF LLY SAGE
Tags BIIB SAGE ESALF
From MarketWatch
At-home Alzheimer’s testing is on the horizon, researchers say
Tickers BIIB ESALF LLY
Tags BIIB ESALF LLY
From MarketWatch
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
Tickers BIIB ESALF LLY SPX
Tags ESALF LLY SPX
From MarketWatch
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
Tickers BIIB ESALF ESALY
Tags Analyst Ratings BIIB Analyst Color
From Benzinga
Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout
Tickers BIIB ESALF LLY
Tags ESALF LLY BIIB
From MarketWatch
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
Tickers BIIB ESALF LLY
Tags ESALF LLY BIIB
From MarketWatch
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
Tickers BIIB ESALF ESALY
Tags General Benzinga ESALY
From Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
Tickers BIIB ESALF ESALY
Tags Health Care Trading Ideas ESALF
From Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
Tickers AAPL AMC AMD AMZN
Tags MULN GME AMZN
From MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
Tickers BIIB CCF CVNA ESALF
Tags ILMN ORCL ESALF
From MarketWatch
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
Tickers BIIB ESALF
Tags ESALF BIIB
From MarketWatch
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags Benzinga ESALY Biotech
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.